Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T04:22:27.603Z Has data issue: false hasContentIssue false
  • English
  • Français

A Quality Assurance Program for Human Immunodeficiency Virus Seropositivity Screening of Dried-Blood Spot Specimens

Published online by Cambridge University Press:  21 June 2016

W. Harry Hannon ,
D. Sue Lewis ,
Wanda K. Jones  and
Mary K. Powell
W. Harry Hannon*
Affiliation:
Division of Environmental Health Laboratory Sciences, Center for Environmental Health and Injury Control, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, CA 30333
D. Sue Lewis
Affiliation:
Division of Environmental Health Laboratory Sciences, Center for Environmental Health and Injury Control, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, CA 30333
Wanda K. Jones
Affiliation:
Division of Training, Training and Laboratory Program Office, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, CA 30333
Mary K. Powell
Affiliation:
Division of Environmental Health Laboratory Sciences, Center for Environmental Health and Injury Control, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, CA 30333
*
Division of Environmental Health Laboratory Sciences, Center for Environmental Health, Centers for Disease Control, Atlanta, CA 30333
Get access Rights & Permissions [Opens in a new window]

Abstract

Epidemiologic projects have been implemented for using dried-blood spot (DBS) specimens routinely collected on filter paper from neonates as a seroepidemiologic resource to monitor seroprevalence of human immunodeficiency virus (HIV) among child-bearing women. To ensure the quality of the data base produced from the national and other epidemiologic surveys, a quality assurance program was developed to interact with all the neonatal screening laboratories. The focus of the Centers for Disease Control's quality assurance program for HIV seropositivity testing of neonatal blood specimens is to maintain a national program to produce, certify, and provide external quality control materials as DBSs on filter paper, to monitor the filter paper matrix, to operate an external performance surveillance program, and to provide other special and consultative services. The dried-blood control and surveillance materials are certified by rigorous testing for accuracy, stability, and homogeneity. Preliminary results from the first performance evaluation of screening laboratories indicated excellent performance.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 1 , January 1989 , pp. 8 - 13
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Guthrie, R. Susi, A: A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–343.CrossRefGoogle ScholarPubMed
2.Vejtorp, M, Leerhoyi: Rubella IgG antibody detection by ELISA using capillary blood samples collected on filter paper and in microtainer tubes. Ada Pathol Microbiol Immunol Scand. 1981;89:369–370.Google ScholarPubMed
3.Kagan, IG, Goldsmith, RS, Zarate-Castaneda, R, et al: Evaluation on serologic tests for studies on Chagas disease. Bull Pan Am Health Organ. 1978;12:341–348.Google Scholar
4.Villa, F, Cartolari, R. Bellentani, S. et al: Hepatitis B virus markers on dried-blood spots. A new tool for epidemiological research. J clin Pathol. 1981;34:810–812.CrossRefGoogle ScholarPubMed
5.Mathews, HM, Fisher, GU, Kagan, IG: Persistence of malaria antibody in Tbbago, West Indies, following eradication, as measured by the indirect hemagglutination test. Am J Trap Med Hyg. 1970;19:581–585.CrossRefGoogle ScholarPubMed
6.Nielsen, CM, Bygbjerg, IC, Vestergaard, BF: Detection of HIV antigens in dilates from whole blood collected on filter paper. Lancet. 1987;i:566–567.CrossRefGoogle Scholar
7.Faradegan, H, Quinn, T, Polk, BF: Detecting antibodies to human immunodrficiency virus in dried blood on filter papers. J Infect Dis. 1987;155:1073–1074.CrossRefGoogle Scholar
8.Hoff, R, Berardi, VP. Weiblen, BJ, et al: Seroprevalence of human immunodeficiency virus among childbearing women: Estimation by testing samples of blood from neonates. N Engl J Med. 1988;318:525–530.CrossRefGoogle Scholar
9.National Committee for Clinical Laboratory Standards (NCCLS). Blood collection on filter paper for neonatal screening programs: Tentative standard. Villanova, Pennsylvania, NCCLS, 19X5 (NCCLS publication L.A4-T).Google Scholar
10.Slazvk, WE, Phillips, DI, Therrell, BL Jr.et al: Effect of lot-to-lot variability in filter paper on the quantification of thyroxin, thyrotropin, and phenylalanine in dried-blood specimens. Clin Chem. 1988;34:53–58.CrossRefGoogle Scholar
11.National Committee for Clinical Laboratory Standards Calibration and control materials for neonatal hypothyroid screening programs: Proposed guideline standard Villanova, Pennsylvania, NCCLS, 1983 (NCCLS publication LAX-P).Google Scholar
12.Resnick, L, Veren, K, Salahuddin, SZ, et al: Stability and inactivation of LV-I under- clinical and laboratory environments. JAMA. 1986;255:1887–1891.CrossRefGoogle Scholar
13.McDougal, JS, Martin, LS, Cort, SP, et al: Thermal inactivation of acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymph-adenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest. 1985;76:875–877.CrossRefGoogle ScholarPubMed
14.Centers for Disease Control: Update: Serologic testing for antibody to human immunodeficiency virus. MMWR. 1988;36:833–840.Google Scholar